In Basilic vein transposition surgery via ultrasound guided supraclavicular block comparison of ropivacaine 0.5% 20ml vs 30ml

Not Applicable

• Conditions: Health Condition 1: N189- Chronic kidney disease, unspecifiedHealth Condition 2: O- Medical and Surgical

• Registration Number: CTRI/2021/12/038674
• Lead Sponsor: SHREE KRISHNA HOSPITA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 February 2022

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Patients ASA (american society of anesthesia) 1-4 physical status

Patients undergoing basilic vein transposition surgery

Exclusion Criteria

1)Patients refusal to regional anesthesia

2) Skin infection located near block injection site

3) Allergy to local anaesthetics

4) Pregnancy

5) Presence of bleeding disorder or coagulopathy

6) Patients with preexisting neurological deficit

7) Psychiatric disorder

8) patient with severe hypotension

9) Severe chronic obstructive or restrictive lung disease

10)Bilateral upper limb surgeries

11)local site anatomical abnormalities

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Compare the onset and duration of sensory and motor blockade in 20ml 0.5% ropivacaine group vs 30ml 0.5% ropivacaine group in patients undergoing basilic vein transposition surgery via ultrasound guided supraclavicular block <br/ ><br>Timepoint: 5,10,15,20 <br/ ><br>, 25,30,60,90,120,150,180,210 minutes

Secondary Outcome Measures

Name	Time	Method
1) Need of infiltration at surgical site after giving ultrasound guided supraclavicular block <br/ ><br>2) Surgeonâ??s satisfaction <br/ ><br>3) vitals monitoringTimepoint: Intraoperatively 10,20,30,40,50,60,70,80,90,100,110,120 minutes